Coronavirus: US to begin distributing Regeneron’s COVID-19 antibody therapy Tuesday
The US government will start distributing Regeneron’s newly authorized COVID-19 antibody combination on Tuesday, beginning with over 30,000 treatment courses, a health official said on Monday.
US officials on a call with reporters said doses will be allocated based on which states have the highest numbers of confirmed cases and hospitalizations, both of which are currently soaring nationwide.
For more coronavirus news, visit our dedicated page.
The US Food and Drug Administration on Saturday issued emergency use authorization for the treatment called REGN-COV2, which combines two monoclonal antibodies, to be used for mild-to-moderate COVID-19 in adults and children who are at high risk of progressing to severe COVID-19.
Regeneron has said it expects to have enough REGEN-COV2 for about 80,000 patients by the end of this month. It expects to have enough doses to treat about 200,000 patients by the first week of January, rising to some 300,000 patients in total by the end of January.
For all the latest headlines follow our Google News channel online or via the app.
The antibody cocktail was among the treatments given to US President Trump during his bout with COVID-19 last month. He declared it a virtual “cure” for COVID-19 at the time.
The treatment belongs to a class of biotech drugs known as monoclonal antibodies, which are manufactured copies of antibodies created by the human body to fight infections.
US regulators earlier this month authorized another antibody treatment for COVID-19 from Eli Lilly and Co. Officials on Monday said the department of Health and Human Services has already helped distribute 120,000 doses of Lilly’s antibody to patients around the country.
More than 250,000 Americans have also been treated for their COVID-19 with antibody-rich convalescent plasma from recovered patients, officials said. Some health experts have argued that there is not enough data to show that convalescent plasma is an effective treatment.
Read more:
Saudi Arabia will make coronavirus vaccine available for free to everyone: Ministry
What is the experimental COVID-19 drug given to US President Trump?
Coronavirus: Regeneron announces more positive results for COVID-19 treatment
-
Coronavirus: UK’s Johnson says there will be no compulsory COVID-19 vaccination
Britain’s government will not force people to have vaccinations against COVID-19, Prime Minister Boris Johnson said on Monday.“There will be no ... Coronavirus -
World airline body IATA develops mobile apps for coronavirus-era travel
Global aviation body IATA is developing a set of mobile apps to help passengers to navigate COVID-19 travel restrictions and securely share test and ... Coronavirus -
Coronavirus: Dos and don'ts of a holiday season amid COVID-19
The US Centers for Disease Control and Prevention advises that with the rapidly increasing number of coronavirus cases, the safest way to celebrate ... Coronavirus -
Coronavirus: Dosing error turns into stroke of luck for AstraZeneca, Oxford vaccine
A stroke of good fortune from a dosing error will pave the way for AstraZeneca and Oxford University to submit their COVID-19 vaccine for regulatory ... Coronavirus